GGrantIndex
Sort

34,240 grants matching atherosclerosis

Dissecting the role of CD8+ T cells in atherosclerosis

$665,467
Chiara Giannarelli · New York University School Of Medicine · R01 · FY2023 · HL

Establishing mechanistic links between the gut microbiome and atherosclerosis

$665,362
Federico E Rey · University Of Wisconsin-Madison · R01 · FY2021 · HL

Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta

$665,332
Alexander Egbe · Mayo Clinic Rochester · R01 · FY2025 · HL

SUBCLINICAL HEART DISEASE IN INSULIN-DEPENDENT DIABETES

$665,289
University Of Colorado Denver · R01 · FY2000 · HL

Integration of spatial transcriptomics, genetics, and histomorphology for causal inference in atherosclerotic cardiovascular disease

$665,187
Muredach P Reilly · Columbia University Health Sciences · R01 · FY2025 · HL

Insulin-Like Growth Factor-1 and Atherosclerosis

$665,154
Patrice Delafontaine Delafontaine · Tulane University Of Louisiana · R01 · FY2024 · HL

MOLECULAR BASIS OF ENDOTHELIAL REMODELING BY FLOW

$665,133
University Of California San Diego · R01 · FY2002 · HL

The Role of Layilin as a Novel Regulator of Platelet Activation and Thromboinflammation

$665,102
Aaron Christopher Petrey · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HL

The Role of Layilin as a Novel Regulator of Platelet Activation and Thromboinflammation

$665,102
Aaron Christopher Petrey · University Of Utah · R01 · FY2023 · HL

Oral Infections and Vascular Disease Epidemiology Study (INVEST)

$665,052
Moise Desvarieux · Columbia University Health Sciences · R01 · FY2016 · DE

Cardiac function as a mechanism for maladaptive brain aging

$665,005
Angela L. Jefferson · Vanderbilt University Medical Center · R01 · FY2017 · AG

Phase resolved ARF optical coherence elastography for intravascular imaging

$664,990
Zhongping Chen · University Of California-Irvine · R01 · FY2015 · HL

Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis

$664,969
Zhenheng Guo · University Of Kentucky · R01 · FY2025 · HL

Targeting smooth muscle cell BMAL1 as a new therapeutic strategy against restenosis

$664,969
Zhenheng Guo · University Of Kentucky · R01 · FY2023 · HL

Phage-based targeted imaging probes and their application to vascular diseases

$664,963
Trevor Douglas · Montana State University - Bozeman · R01 · FY2012 · EB

Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians

$664,926
Anand Kumar Rohatgi · Ut Southwestern Medical Center · R01 · FY2023 · HL

Long Term Effects of Subclinical CAD on Cardiac Function

$664,682
La Biomed Res Inst/ Harbor Ucla Med Ctr · R01 · FY2004 · HL

Human LincRNAs in Macrophage Biology and Related Cardiometabolic Diseases

$664,674
Muredach P Reilly · Columbia University Health Sciences · R01 · FY2020 · HL

Vascular Toxicity of Benzene

$664,616
Sanjay Srivastava · University Of Louisville · R01 · FY2024 · ES

Vascular Toxicity of Benzene

$664,616
Sanjay Srivastava · University Of Louisville · R01 · FY2025 · ES

Platelets in Cardiovascular Biology and Pathology

$664,586
Denisa D Wagner · Massachusetts Institute Of Technology · P01 · FY2008 · HL

Long-Acting RNAi Therapy for Atherosclerosis and Insulin Resistance

$664,531
Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2024 · HL

Blood Brain Barrier Changes Induced by Pain

$664,448
Thomas Paul Davis · University Of Arizona · R01 · FY2010 · NS

Development of a multi-modal targeted nanotherapeutic to prevent restenosis in an atherosclerotic environment

$664,358
Melina Rae Kibbe · University Of Virginia · R01 · FY2022 · HL

Dose-response to resistance exercise on cardiovascular health

$664,350
Duck-Chul Lee · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · HL